I had the pleasure of sitting in on a zoom call with a CEO of another Biomedical company recently and he made mention of big pharma always asking the question of whether a treatment can be done via the skin. I think this is a really exciting time for the company and look forward to the onboarding of more patients. On another note, I thought it was interesting to see mention of 'TGA Pre-submission Request – Q1 2024' in the presentation slides as I might have missed it but I didn't think TGA was back on the company's radar.
Ann: OncoSil onboards first patient in PANCOSIL Clinical Trial, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |